ATF7IP and acute lymphoblastic leukemia: Non-mutant ATF7IP-JAK2 Ba/F3 cells had similar rux sensitivity to that of ex vivo human leukemic cells expressing ATF7IP-JAK2 (LD50 438 nM)14, validating our system to model JAK2r ALL.